A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway
Summary: Neurofibromatosis type 2 is an autosomal dominant multiple neoplasia syndrome and is usually caused by mutations in the neurofibromin 2 (NF2) gene, which encodes a tumor suppressor and initiates the Hippo pathway. However, the mechanism by which NF2 functions in the Hippo pathway isn’t full...
Main Authors: | Zexiao Jia, Shuxu Yang, Mengyao Li, Zhaoying Lei, Xue Ding, Mingjie Fan, Dixian Wang, Dajiang Xie, Hui Zhou, Yue Qiu, Qianqian Zhuang, Dan Li, Wei Yang, Xuchen Qi, Xiaohui Cang, Jing-Wei Zhao, Wenqi Wang, Aifu Lin, Qingfeng Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222015474 |
Similar Items
-
PML surfs into HIPPO tumor suppressor pathway
by: Sabrina eStrano, et al.
Published: (2013-03-01) -
Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance
by: Patrick J. Lenehan, et al.
Published: (2021-07-01) -
Hepatic Huwe1 loss protects mice from non-alcoholic fatty liver disease through lipid metabolic rewiring
by: William W. Feng, et al.
Published: (2023-12-01) -
Inactivation of the Hippo tumor suppressor pathway promotes melanoma
by: Marc A. Vittoria, et al.
Published: (2022-06-01) -
Sarco(endo)plasmic reticulum Ca2+-ATPase function is impaired in skeletal and cardiac muscles from young DBA/2J mdx mice
by: Riley E.G. Cleverdon, et al.
Published: (2022-09-01)